Compositions and methods for treating joints
First Claim
Patent Images
1. A kit for treating joints, comprising:
- a first component comprising high molecular weight hyaluronic acid;
a second component comprising a lyophilized glycosaminoglycan, the second component being separate from the first component and effective to at least temporarily reduce the viscosity of the first component; and
a syringe for injecting a mixture of the first and second components.
9 Assignments
0 Petitions
Accused Products
Abstract
Compositions and methods are provided for treating joint conditions, such as osteoarthritis and/or the pain associated therewith. The compositions and methods utilize a first component, namely hyaluraonic acid (“HA”), in combination with a lyophilized second component that is effective to at least temporarily reduce the viscosity of the HA. In an exemplary embodiment, the second component is one or more glycosaminoglycans (“GAG”), such as chondroitin sulfate (“CS”), including CS4 and/or CS6, dermatan sulfate, heparin, heparan sulfate, and keratan sulfate. The composition can optionally include other joint supplements, such as glucosamine (“GlcN”).
-
Citations
24 Claims
-
1. A kit for treating joints, comprising:
-
a first component comprising high molecular weight hyaluronic acid; a second component comprising a lyophilized glycosaminoglycan, the second component being separate from the first component and effective to at least temporarily reduce the viscosity of the first component; and a syringe for injecting a mixture of the first and second components. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
-
13. A method for treating joints, comprising:
- combining a first component comprising hyaluronic acid with a separate second component comprising a lyophilized glycosaminoglycan to form a mixture, wherein a viscosity of the mixture is at least temporarily less than a viscosity of the first component; and
injecting the mixture into a joint. - View Dependent Claims (14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24)
- combining a first component comprising hyaluronic acid with a separate second component comprising a lyophilized glycosaminoglycan to form a mixture, wherein a viscosity of the mixture is at least temporarily less than a viscosity of the first component; and
Specification